Toronto Innovation Acceleration Partners logo

Toronto Innovation Acceleration Partners

North America, Ontario, Canada, Toronto

Description

Toronto Innovation Acceleration Partners is a member-driven not-for-profit organization

Investor Profile

Toronto Innovation Acceleration Partners has backed more than 11 startups, with 3 new investments in the last 12 months alone. The firm has led 1 rounds, about 9% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Grant rounds (top funding stages).
  • Majority of deals are located in Canada, United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Artificial Intelligence (AI).
  • Led 1 rounds in the past year.

Stage Focus

  • Seed (55%)
  • Series A (18%)
  • Grant (9%)
  • Series C (9%)
  • Series Unknown (9%)

Country Focus

  • Canada (91%)
  • United States (9%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Life Science
  • Therapeutics
  • Energy
  • Medical
  • Genetics
  • Information Technology
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Toronto Innovation Acceleration Partners frequently co-invest with?

HAX
North America, California, United States, San Francisco
Co-Investments: 1
Cantos
North America, California, United States, San Francisco
Co-Investments: 1
Forum Ventures
North America, New York, United States, New York
Co-Investments: 1
AV8 Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 1
FACIT
North America, Ontario, Canada, Toronto
Co-Investments: 2
Ontario Centre of Innovation
North America, Ontario, Canada, Toronto
Co-Investments: 2
Hike Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Garage Capital
North America, California, United States, Ontario
Co-Investments: 1
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by Toronto Innovation Acceleration Partners?

Grey Matter Neurosciences

Toronto, Ontario, Canada

Grey Matter Neurosciences develops new medical devices and drug-device combinations to treat age-related brain illnesses.

MedicalMedical DeviceNeuroscience
SeedJan 23, 2025
Amount Raised: $14,000,000
Radiant Biotherapeutics

Toronto, Ontario, Canada

Radiant is a biotechnology company developing the next generation of multi-specificity.

BiotechnologyTherapeutics
Series ASep 11, 2024
Amount Raised: $35,000,000
HDAX Therapeutics

Toronto, Ontario, Canada

HDAC6, small molecule, peripheral neuropathy, cardiometabolic, pharmaceuticals, biotech, biopharma, life science

BiopharmaBiotechnologyLife SciencePharmaceutical
SeedSep 5, 2024
Amount Raised: $3,185,067
Spero Analytics

Toronto, Ontario, Canada

Monitor anything, anywhere, all the time using Spero's off-the-grid wireless mesh networking system

EnergyEnvironmental EngineeringInternet of ThingsNetwork Hardware
SeedSep 1, 2023
Amount Raised: $155,496
Mazlite

Toronto, Ontario, Canada

Mazlite provides an Industrial IoT platform for spray monitoring and digitization.

AgricultureArtificial Intelligence (AI)AutomotiveFood and BeveragePharmaceutical
SeedDec 31, 2022
Phenomic AI

Waltham, Massachusetts, United States

Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.

Artificial Intelligence (AI)BiotechnologyGeneticsInformation TechnologyLife ScienceMachine LearningTherapeutics
SeedOct 7, 2020
Amount Raised: $6,000,000
Bright Angel Therapeutics

Toronto, Ontario, Canada

Bright Angel Therapeutics is developing new drugs that can prevent or revert the emergence of antifungal resistance.

Biotechnology
SeedDec 3, 2019
Flybits

Toronto, Ontario, Canada

The Experience Design platform for context aware, data-led banking

AnalyticsDeveloper ToolsEnterprise SoftwareFinancial ServicesFinTechMobilePredictive AnalyticsSaaS
Series CJul 16, 2019
Amount Raised: $35,000,000
Zucara Therapeutics

Vancouver, British Columbia, Canada

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

BiotechnologyDiabetesPharmaceutical
GrantFeb 8, 2018
Amount Raised: $1,000,000
QD Solar

Toronto, Ontario, Canada

QD Solar is a technology company based in Canada that develops photovoltaic cells that use colloidal quantum dot technology.

EnergyManufacturingNanotechnologyRenewable EnergySolar
Series AFeb 13, 2017
Amount Raised: $1,912,464